Celyad Oncology
The computed 12-month bankruptcy probability of Celyad Oncology is 0.3% (very low). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 19 yrs |
| Board | 14 |
| Locations | 1 |
| Publications | 117 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 10-06-2026 | 2026-00158811 |
| 31-12-2024 | volledig | 21-05-2025 | 2025-00103792 |
| 31-12-2024 | consolidatie | 22-05-2025 | 2025-00103809 |
| 31-12-2023 | volledig | 28-05-2024 | 2024-00103440 |
| 31-12-2023 | consolidatie | 28-05-2024 | 2024-00103703 |
| 31-12-2022 | volledig | 05-06-2023 | 2023-00109903 |
| 31-12-2022 | consolidatie | 05-06-2023 | 2023-00109579 |
| 31-12-2021 | volledig | 24-05-2022 | 2022-20034782 |
| 31-12-2021 | consolidatie | 24-05-2022 | 2022-20044151 |
| 31-12-2020 | volledig | 25-05-2021 | 2021-15600194 |
-
Resilient IDLegal entityDaily management· perm. rep.: Hannes IserentantState Gazette act 25163089 (29-12-2025)Current12-11-2025 → present
-
Current31-10-2025 → present
2 events
- 08-06-2026 Mandate renewed· Director
- 31-10-2025 Appointed· Director
-
Current02-12-2024 → present
-
Current20-12-2023 → present
-
Current20-12-2023 → present
2 events
- 08-06-2026 Mandate renewed· Director
- 20-12-2023 Appointed· Director
-
Current20-12-2023 → present
2 events
- 08-06-2026 Mandate renewed· Director
- 20-12-2023 Appointed· Director
Show 8 more sitting directors
-
Mel Management srlLegal entityDaily management· perm. rep.: Michel LussierState Gazette act 24019821 (31-01-2024)Current01-12-2023 → present
6 events
- 01-12-2023 Appointed· Daily management
- 14-11-2023 Resigned· Director
- 17-04-2023 Resigned· Daily management
- 24-06-2022 Appointed· Daily management
- 05-04-2022 Mandate renewed· Director
- 04-12-2020 Appointed· Director
-
CFIP CLYD LLCLegal entityDirector· perm. rep.: Michel LussierState Gazette act 26072705 (08-06-2026)Current14-11-2023 → present
2 events
- 08-06-2026 Mandate renewed· Director
- 14-11-2023 Appointed· Director
-
Hilde Windels BVLegal entityDirector· perm. rep.: Hilde WindelsState Gazette act 26072705 (08-06-2026)Current13-11-2023 → present
2 events
- 08-06-2026 Mandate renewed· Director
- 13-11-2023 Appointed· Director
-
SYGA BIO SARLLegal entityDirector· perm. rep.: Georges RawadiState Gazette act 23088867 (11-07-2023)Current17-04-2023 → present
2 events
- 11-07-2023 Appointed· Director
- 17-04-2023 Appointed· Daily management
-
Current20-01-2022 → present
3 events
- 18-06-2024 Mandate renewed· Director
- 31-05-2022 Appointed· Director
- 20-01-2022 Appointed· Director
-
Current17-12-2020 → present
3 events
- 16-06-2025 Mandate renewed· Director
- 05-04-2022 Mandate renewed· Director
- 17-12-2020 Appointed· Director
-
Current23-06-2020 → present
3 events
- 08-06-2026 Mandate renewed· Director
- 18-06-2024 Mandate renewed· Director
- 23-06-2020 Appointed· Director
-
Current20-01-2011 → present
6 events
- 18-06-2024 Mandate renewed· Director
- 23-06-2020 Mandate renewed· Director
- 11-09-2019 Appointed· Membre du comité de détermination du prix
- 09-05-2016 Mandate renewed· Director
- 20-01-2011 Resigned· Director
- 20-01-2011 Appointed· Director
Historic, not recently confirmed (7)
-
R.A.D. Life Sciences BVLegal entityDirector· perm. rep.: Rudy DekeyserState Gazette act 20070496 (23-06-2020)Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2018
-
SA TOLEFILegal entityDirector· perm. rep.: Serge GobletState Gazette act 18093303 (15-06-2018)Not recently confirmedlast confirmed in an act from 2018
-
LSS Consulting SPRLLegal entityDirector· perm. rep.: Christian HomsyState Gazette act 16144482 (19-10-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 09-05-2016 Mandate renewed· Director
- 21-12-2015 Appointed· Managing director
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2011
-
Pienter-Jan BVBALegal entityDirector· perm. rep.: Chris BuyseState Gazette act 11028770 (22-02-2011)Not recently confirmedlast confirmed in an act from 2011
Former directors (20)
-
Former29-12-2021 → 05-12-2025
4 events
- 05-12-2025 Resigned· Director
- 18-06-2024 Mandate renewed· Director
- 31-05-2022 Appointed· Director
- 29-12-2021 Appointed· Director
-
Former01-10-2024 → 01-12-2025
2 events
- 01-12-2025 Resigned· Daily management
- 01-10-2024 Appointed· Daily management
-
Former15-06-2018 → 13-11-2023
4 events
- 13-11-2023 Resigned· Director
- 24-06-2022 Appointed· Director
- 31-05-2022 Mandate renewed· Director
- 15-06-2018 Appointed· Director
-
Former22-09-2015 → 13-12-2022
7 events
- 13-12-2022 Resigned· Director
- 23-06-2020 Mandate renewed· Director
- 11-09-2019 Appointed· Membre du comité de détermination du prix
- 14-05-2018 Appointed· Membre du comité de détermination du prix
- 09-05-2016 Mandate renewed· Director
- 22-09-2015 Appointed· Director
- 20-01-2011 Resigned· Director
-
Former01-04-2019 → 24-06-2022
6 events
- 24-06-2022 Resigned· Director
- 15-04-2020 Mandate renewed· Director
- 07-01-2020 Appointed· Director
- 28-11-2019 Appointed· Managing director
- 11-09-2019 Appointed· Membre du comité de détermination du prix
- 01-04-2019 Appointed· Daily management
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent Statutory auditor · represented by Christophe Pelzer |
- | 08-06-2026 → present |
Show 4 earlier auditors
| BDO Réviseurs d'Entreprises SRL Statutory auditor · represented by Christophe Pelzer succeeded by BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES in 2026 |
- | 28-03-2024 → 08-06-2026 |
| CVBA BDO Bedrijfsrevisoren - Réviseurs d'entreprises Statutory auditor · represented by Bert Kegels succeeded by CVBA E&Y Bedrijfsrevisoren - Réviseurs d'entreprises in 2020 |
- | 30-06-2017 → 23-06-2020 |
| CVBA E&Y Bedrijfsrevisoren - Réviseurs d'entreprises Statutory auditor · represented by Carlo-Sébastien D'addario succeeded by VCBA BDO Bedrijfsrevisoren - Réviseurs d'entreprises in 2023 |
- | 23-06-2020 → 11-07-2023 |
| VCBA BDO Bedrijfsrevisoren - Réviseurs d'entreprises Statutory auditor · represented by Bert Kegels succeeded by BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISES in 2026 |
- | 11-07-2023 → 08-06-2026 |
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 24-07-2007 |
| Status | Active |
| Postal code | 1435 |
Show 2 more network connections
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Of the 115 Belgian State Gazette acts we know for this company, 113 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
31-07-2026 Act object · Notarial deed · Board meeting · Capital increase
- Act object: STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS · Celyad Oncology
- Publication: 31/07/2026 · Celyad Oncology
- Filing: 29-07-2026 · Celyad Oncology
- Notarial deed: 16/07/2026 · Celyad Oncology
- Board meeting: 16/07/2026 · Celyad Oncology
- Capital increase: after: 9.716.154,53 EUR, delta: 500.000,00 EUR, amount: 9716154.53, before: 9.216.154,53 EUR, currency: EUR, liberation: 100%, shares_issued: 2.500.000, price_per_share: 0,20 EUR, subscription_type: numéraire · Celyad Oncology
- Capital: amount: 9716154.53, shares: 47.261.905, currency: EUR · Celyad Oncology
- Statute amendment: Article 5 replaced to reflect new capital and share count · Celyad Oncology
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
"value": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 31/07/2026 - Annexes du Moniteur belge",
"value": "31/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-29",
"type": "filing",
"quote": "D\u00E9pos\u00E9 29-07-2026",
"value": "29-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-16",
"type": "notarial_deed",
"quote": "Ce jour, le seize juillet deux mille vingt-six. (...) Par devant moi, Tim CARNEWAL, notaire",
"value": "16/07/2026",
"object": "e2",
"subject": "e1"
},
{
"date": "2026-07-16",
"type": "board_meeting",
"quote": "Ce jour, le seize juillet deux mille vingt-six. (...) S\u0027EST R\u00C9UNI le conseil d\u0027administration",
"value": "16/07/2026",
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "Le conseil d\u0027administration d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 500.000,00 EUR, pour le porter de 9.216.154,53 EUR \u00E0 9.716.154,53 EUR. L\u2019augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire et par l\u2019\u00E9mission de 2.500.000 nouvelles actions... au prix de 0,20 EUR chacune... lib\u00E9r\u00E9es \u00E0 concurrence de 100%",
"value": {
"after": "9.716.154,53 EUR",
"delta": "500.000,00 EUR",
"amount": 9716154.53,
"before": "9.216.154,53 EUR",
"currency": "EUR",
"liberation": "100%",
"shares_issued": "2.500.000",
"price_per_share": "0,20 EUR",
"subscription_type": "num\u00E9raire"
},
"amount": 500000.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"after": "9.716.154,53 EUR",
"delta": "500.000,00 EUR",
"before": "9.216.154,53 EUR",
"liberation": "100%",
"shares_issued": "2.500.000",
"price_per_share": "0,20 EUR",
"subscription_type": "num\u00E9raire"
}
},
{
"type": "capital",
"quote": "Le capital de la soci\u00E9t\u00E9 est fix\u00E9 \u00E0 neuf millions sept cent seize mille cent cinquante-quatre euros cinquante-trois cents (\u20AC 9.716.154,53), repr\u00E9sent\u00E9 par quarante-sept millions deux cent soixante et un mille neuf cent cinq (47.261.905) actions",
"value": {
"amount": 9716154.53,
"shares": "47.261.905",
"currency": "EUR"
},
"amount": 9716154.53,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "9.716.154,53 EUR",
"shares": "47.261.905"
}
},
{
"type": "statute_amendment",
"quote": "DIXI\u00C8ME R\u00C9SOLUTION : Modification de l\u2019article 5 des statuts. Afin de mettre les statuts en concordance avec les r\u00E9solutions prises, le conseil d\u0027administration d\u00E9cide de remplacer l\u0027article 5 des statuts par le texte suivant",
"value": "Article 5 replaced to reflect new capital and share count",
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 4341,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0891.118.115",
"kind": "company",
"name": "Celyad Oncology",
"attrs": {
"seat": "Rue Emile Francqui 6, 1435 Mont-Saint-Guibert",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Tim CARNEWAL",
"attrs": {
"role": "notaire",
"address": "Bruxelles, avenue Lloyd George 11"
}
}
]
}08-06-2026 General meeting · Auditor mandate · Officer reappointment · Power of attorney
- Filing: 2026-05-29 · CELYAD ONCOLOGY
- General meeting: 2026-05-20 · CELYAD ONCOLOGY
- Auditor mandate: end: 2028-12-31, start: 2026-05-20, duration: trois ans · CELYAD ONCOLOGY
- Officer reappointment: end: 2028-12-31, role: administrateur, start: 2026-05-20, duration: trois ans · CELYAD ONCOLOGY
- Officer reappointment: end: 2026-12-31, role: administrateur, start: 2026-05-20, duration: 1 an · CELYAD ONCOLOGY
- Officer reappointment: end: 2026-12-31, role: administrateur, start: 2026-05-20, duration: 1 an · CELYAD ONCOLOGY
- Officer reappointment: end: 2028-12-31, role: administrateur, start: 2026-05-20, duration: 3 ans · CELYAD ONCOLOGY
- Officer reappointment: end: 2028-12-31, role: administrateur, start: 2026-05-20, duration: 3 ans · CELYAD ONCOLOGY
- Officer reappointment: end: 2028-12-31, role: administrateur, start: 2026-05-20, duration: 3 ans · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Power of attorney: date: 2026-05-20, grantee: chaque membre du conseil d'administration de la Société, agissant seul, purpose: poser, exécuter et signer tous les documents, instruments, démarches et formalités et afin de donner toutes les instructions nécessaires ou utiles afin d'exécuter les décisions précitées, granted_by: assemblée générale · CELYAD ONCOLOGY
- Publication: 2026-06-08
- Act object: Renouvellement du mandat du commissaire et renouvellement de mandats
Technical details
{
"facts": [
{
"type": "filing",
"quote": "29 MAI 2026",
"value": "2026-05-29",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait du proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des acrionnaires du 20 mai 2026",
"value": "2026-05-20",
"object": null,
"subject": "e1"
},
{
"type": "auditor_mandate",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de renouveler le mandat de VCBA BDO Bedrijfsrevisoren - R\u00E9viseurs d\u0027entreprises ... pour une dur\u00E9e de trois ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E8rale ordinaire statuant sur les comptes cl\u00F4tur\u00E9s au 31 d\u00E8cembre 2028.",
"value": {
"end": "2028-12-31",
"start": "2026-05-20",
"duration": "trois ans"
},
"object": "e2",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de confirmer la nomination de Sharon Roberg-Perez ... et de renouveler son mandat pour une dur\u00E8e de trois ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire approuvant les comptes cl\u00F4tur\u00E9s le 31 d\u00E9cembre 2028.",
"value": {
"end": "2028-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "trois ans"
},
"object": "e4",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Dominic Piscitelli pour une dur\u00E9e de 1 an, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E8rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026.",
"value": {
"end": "2026-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "1 an"
},
"object": "e5",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E8cide de renouveler le mandat d\u0027administrateur de Hilde Windels BV, repr\u00E9sent\u00E9e par Hilde Windels, pour une dur\u00E9e de 1 an, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026.",
"value": {
"end": "2026-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "1 an"
},
"object": "e7",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de CFIP CLYD LLC, repr\u00E9sent\u00E9e par Michel Lussier, pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2028.",
"value": {
"end": "2028-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "3 ans"
},
"object": "e8",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Sage Mandel pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2028.",
"value": {
"end": "2028-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "3 ans"
},
"object": "e10",
"subject": "e1"
},
{
"type": "officer_reappointment",
"quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Jonathan James pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2028.",
"value": {
"end": "2028-12-31",
"role": "administrateur",
"start": "2026-05-20",
"duration": "3 ans"
},
"object": "e11",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 Mme. An Phan, Head of Legal, Resilient ID BV, repr\u00E9sent\u00E9e par M. Hannes Iserentant, Directeur G\u00E9n\u00E9ral et/ou F\u0026C Consulting SRL, repr\u00E9sent\u00E9e par M. David Georges, VP Finance et Administration, et/ou Me Adrien Lanotte, Me Elise Hamesse et/ou \u00E0 tout avocat du cabinet Harvest Avocats, ou \u00E0 chaque membre du conseil d\u0027administration de la Soci\u00E9t\u00E9, agissant seul, chacun avec pouvoir de substitution, afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e12",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 ... F\u0026C Consulting SRL, repr\u00E9sent\u00E9e par M. David Georges, VP Finance et Administration ... afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e15",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 ... Me Adrien Lanotte ... afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e17",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 ... Me Elise Hamesse ... afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e18",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 ... tout avocat du cabinet Harvest Avocats ... afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e19",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027octroyer une procuration \u00E0 ... chaque membre du conseil d\u0027administration de la Soci\u00E9t\u00E9, agissant seul ... afin de poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"value": {
"date": "2026-05-20",
"grantee": "chaque membre du conseil d\u0027administration de la Soci\u00E9t\u00E9, agissant seul",
"purpose": "poser, ex\u00E9cuter et signer tous les documents, instruments, d\u00E9marches et formalit\u00E9s et afin de donner toutes les instructions n\u00E9cessaires ou utiles afin d\u0027ex\u00E9cuter les d\u00E9cisions pr\u00E9cit\u00E9es",
"granted_by": "assembl\u00E9e g\u00E9n\u00E9rale"
},
"object": "e1",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 08/06/2026",
"value": "2026-06-08",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Renouvellement du mandat du commissaire et renouvellement de mandats",
"value": "Renouvellement du mandat du commissaire et renouvellement de mandats",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 5517,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0891.118.115",
"kind": "company",
"name": "CELYAD ONCOLOGY",
"attrs": {
"seat": "Rue Emile Francqui 6, 1435 Mont-Saint-Guibert",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": "0431.088.289",
"kind": "org",
"name": "VCBA BDO Bedrijfsrevisoren - R\u00E9viseurs d\u0027entreprises",
"attrs": {
"seat": "1930 Zaventem, The Corporate Village, Da Vincilaan 9, boite E.6, Belgique"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Christophe Pelzer",
"attrs": {
"role": "repr\u00E9sentant de VCBA BDO"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Sharon Roberg-Perez",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Dominic Piscitelli",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Hilde Windels",
"attrs": {
"role": "repr\u00E9sentant de Hilde Windels BV"
}
},
{
"id": "e7",
"kbo": null,
"kind": "org",
"name": "Hilde Windels BV",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e8",
"kbo": null,
"kind": "org",
"name": "CFIP CLYD LLC",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Michel Lussier",
"attrs": {
"role": "repr\u00E9sentant de CFIP CLYD LLC"
}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Sage Mandel",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Jonathan James",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "An Phan",
"attrs": {
"role": "Head of Legal, Resilient ID BV"
}
},
{
"id": "e13",
"kbo": null,
"kind": "org",
"name": "Resilient ID BV",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Hannes Iserentant",
"attrs": {
"role": "Directeur G\u00E9n\u00E9ral de Resilient ID BV"
}
},
{
"id": "e15",
"kbo": null,
"kind": "org",
"name": "F\u0026C Consulting SRL",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "David Georges",
"attrs": {
"role": "VP Finance et Administration de F\u0026C Consulting SRL"
}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Adrien Lanotte",
"attrs": {
"role": "avocat"
}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Elise Hamesse",
"attrs": {
"role": "avocat, Mandataire"
}
},
{
"id": "e19",
"kbo": null,
"kind": "org",
"name": "Harvest Avocats",
"attrs": {}
}
]
}12-03-2026 Ami Patel Shah resigns as director
- Ami Patel Shah, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ami Patel Shah",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-05",
"evidence_quote": "D\u00E9mission de Ami Patel Shah de son poste d\u0027administrateur"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}30-01-2026 Matthew Kane resigns as daily management
- Matthew Kane, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_out",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Matthew Kane",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-01",
"evidence_quote": "D\u00E9mission de Matthew Kane de son poste de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}29-12-2025 Hannes Iserentant appointed as daily management
- Hannes Iserentant, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Hannes Iserentant",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1014377401",
"name": "Resilient ID, SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-11-12",
"evidence_quote": "Le conseil d\u0027administration a approuv\u00E9 la nomination de Resilient ID, SRL, ayant son si\u00E8ge au 4 Sint-Geertruibos, 3220 Holsbeek, immatricul\u00E9e aupr\u00E8s de la Banque Carrefour des Entreprises sous le num\u00E9ro 1014.377.401, repr\u00E9sent\u00E9e par Hannes Iserentant, en tant que d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re / D"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}31-10-2025 Sharon Roberg-Perez appointed as director
- Sharon Roberg-Perez, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sharon Roberg-Perez",
"address": null,
"birth_date": null
},
"evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 7:88 du CSA et \u00E0 l\u0027article 13 des statuts de la Soci\u00E9t\u00E9 le Conseil d\u00E9cide de coopter Mme Sharon Roberg-Perez, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9 pour pourvoir \u00E0 cette vacance et pour terminer le mandat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}15-10-2025 Registered office moved from Mont-Saint-Guibert to Mont Saint Guibert
- Rue André Dumont 9, 1435 Mont-Saint-Guibert → Rue Emile Francqui 6, 1435 Mont Saint Guibert
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mont Saint Guibert",
"region": "Brussels",
"street": "Rue Emile Francqui",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "6"
},
"old_address": {
"city": "Mont-Saint-Guibert",
"region": "Brussels",
"street": "Rue Andr\u00E9 Dumont",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "9"
},
"effective_date": "2025-10-01",
"evidence_quote": "Le Conseil d\u0027administration d\u00E9cide de transf\u00E9rer le si\u00E8ge social de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: 6 rue Emile Francqui \u00E0 1435 Mont Saint Guibert. Ce transfert de si\u00E8ge prend effet le 1er octobre 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}21-08-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-08-05",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}16-06-2025 Marina Udier Blagovic reappointed as director
- Marina Udier Blagovic, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marina Udier Blagovic",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Marina Udier Blagovic pour une dur\u00E9e de 2 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}05-12-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-12-02",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 chaque administrateur de la Soci\u00E9t\u00E9, \u00E0 Madame An Phan, Head of Legal, et Monsieur David Georges, VP Finance and Administration, ainsi qu\u2019\u00E0 Adrien Lanotte, Antoine Clerbaux et tout autre avocat ou collaborateur du cabinet d\u2019avocats \u00AB Harvest Avocats \u00BB SRL qui, \u00E0 cet effet, \u00E9lisent domicile \u00E0 1170 Watermael-Boitsfort, boulevard du Souverain 100, chacun pouvant agir individuellement et avec facult\u00E9 de subd\u00E9l\u00E9gation, pour (i) d\u00E9livrer, ex\u00E9cuter, parapher et signer tous documents et actes, (ii) ex\u00E9cuter les r\u00E9solutions qui pr\u00E9c\u00E8dent, (iii) accomplir toutes formalit\u00E9s et, plus particuli\u00E8rement, les formalit\u00E9s aupr\u00E8s d\u2019un guichet d\u2019entreprise, en vue d\u2019assurer l\u2019inscription et/ou la modification des donn\u00E9es dans la Banque-Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e et, (iv) le cas \u00E9ch\u00E9ant, assurer la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge.",
"holder_kbo": "0891118115",
"holder_name": "Harvest Avocats",
"scope_categories": [
"publication",
"KBO",
"tax",
"filing",
"coordination"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}20-11-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}11-10-2024 Matthew Kane appointed as daily management
- Matthew Kane, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Matthew Kane",
"address": null,
"birth_date": null
},
"effective_date": "2024-10-01",
"evidence_quote": "Sur recommandation du Comit\u00E9 de R\u00E9mun\u00E9ration et de Nomination, le Conseil d\u0027administration a approuv\u00E9 la nomination de Matthew Kane en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re (CEO) de la Soci\u00E9t\u00E9, avec une date d\u0027effet au 1er octobre 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}03-10-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-10-03",
"filing_date": "2024-10-01",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2024-09-30",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0891.118.115",
"name": "Celyad Oncology",
"role": "other",
"address": "Rue Andr\u00E9 Dumont 9, 1435 Mont-Saint-Guibert",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:191",
"1:27",
"43"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 1315000,
"real_estate_included": false,
"patrimony_description": "L\u0027op\u00E9ration consiste en l\u0027\u00E9mission de 1 315 000 droits de souscription \u00E0 titre gratuit, permettant aux membres du personnel de la soci\u00E9t\u00E9 de souscrire \u00E0 de nouvelles actions ordinaires. Le capital sera augment\u00E9 \u00E0 concurrence du montant total des droits exerc\u00E9s, avec cr\u00E9ation de jusqu\u0027\u00E0 1 315 000 nouvelles actions. Le prix d\u0027exercice sera d\u00E9termin\u00E9 selon les r\u00E8gles de la loi du 26 mars 1999 relativ",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "Celyad Oncology",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le conseil d\u0027administration de Celyad Oncology, soci\u00E9t\u00E9 anonyme, a d\u00E9cid\u00E9 d\u0027\u00E9mettre 1 315 000 droits de souscription \u00E0 titre gratuit aux membres du personnel, conform\u00E9ment \u00E0 l\u0027article 7:191 de la loi sur les soci\u00E9t\u00E9s (CSA). Ces droits permettent l\u0027acquisition d\u0027actions ordinaires nouvelles, dont le prix d\u0027exercice sera fix\u00E9 selon les cours boursiers. Le capital sera augment\u00E9 sous condition suspensive de l\u0027exercice des droits. Le conseil conserve tous pouvoirs pour d\u00E9terminer les b\u00E9n\u00E9ficiaires et organiser l\u0027offre.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une liste de pr\u00E9sences",
"huit procurations",
"le rapport sp\u00E9cial du conseil d\u0027administration",
"le rapport sp\u00E9cial du commissaire"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}18-06-2024 4 reappointed
- Dominic Piscitelli, Bestuurder
- Serge Goblet, Bestuurder
- Ami Patel Shah, Bestuurder
- Christopher LiPuma, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dominic Piscitelli",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Dominic Piscitelli pour une dur\u00E9e de 2 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2025."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Serge Goblet",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Serge Goblet pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ami Patel Shah",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Ami Patel Shah pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christopher LiPuma",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat d\u0027administrateur de Christopher LiPuma pour une dur\u00E9e de 3 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2026."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}13-05-2024 Capital decrease of €24,732,646.07 to €8,216,154.63
- €32.948.800,70 → €8.216.154,63
Technical details
{
"events": [
{
"kind": "capital_decrease",
"amount": 24732646.07,
"currency": "EUR",
"after_eur": 8216154.63,
"delta_eur": -24732646.07,
"before_eur": 32948800.7,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-05-06",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital par apurement des pertes d\u0027un montant de vingt-quatre millions sept cent trente-deux mille six cent quarante-six euros et sept centimes (\u20AC 24.732.646,07), pour le ramener de trente-deux millions neuf cent quarante-huit mille huit cents euros et septante centimes (\u20AC 32.948.800,70) \u00E0 huit millions deux cent seize mille cent cinquante-quatre euros et soixante-trois centimes (\u20AC 8.216.154,63).",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}16-04-2024 Christophe Pelzer reappointed as statutory auditor
- Christophe Pelzer, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Christophe Pelzer",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-03-28",
"evidence_quote": "Suite \u00E0 la d\u00E9cision de BDO R\u00E9viseurs d\u0027Entreprises SRL, il a \u00E9t\u00E9 d\u00E9cid\u00E9 d\u0027acter ce 28 mars 2024 que Monsieur Christophe Pelzer agit dor\u00E9navant en tant que repr\u00E9sentant permanent de BDO R\u00E9viseurs d\u0027entreprises dans le cadre du mandat de commissaire exerc\u00E9 aupr\u00E8s de la SA CELYAD ONCOLOGY, qui viendra "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}31-01-2024 Michel Lussier appointed as daily management
- Michel Lussier, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management srl",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-12-01",
"evidence_quote": "Le conseil a approuv\u00E9 la nomination de Mel Management srl, repr\u00E9sent\u00E9e par Michel Lussier, en tant que d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re/CEO ad interim de la Soci\u00E9t\u00E9, avec effet au 1er d\u00E9cembre 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}11-01-2024 2 directors appointed, 2 resigning
- Hilde Windels, Bestuurder
- Michel Lussier, Bestuurder
- Hilde Windels, Bestuurder
- Michel Lussier, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-13",
"evidence_quote": "Les Administrateurs prennent acte, et pour autant que de besoin, acceptent la d\u00E9mission des personnes suivantes: -Hilde Windels en sa qualit\u00E9 d\u0027administrateur et de Pr\u00E9sidente du conseil d\u0027administration de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-11-14",
"evidence_quote": "Les Administrateurs prennent acte, et pour autant que de besoin, acceptent la d\u00E9mission des personnes suivantes: ... -Mel Management SRL, repr\u00E9sent\u00E9e par Michel Lussier, en sa qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 14 novembre 2023."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-11-13",
"evidence_quote": "les Administrateurs d\u00E9cident de coopter: -Hilde Windels BV, ayant son si\u00E8ge \u00E0 9000 Gent, Kasteellaan 89, repr\u00E9sent\u00E9e par Madame Hilde Windels avec effet imm\u00E9diat"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "CFIP CLYD LLC",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-11-14",
"evidence_quote": "les Administrateurs d\u00E9cident de coopter: ... -CFIP CLYD LLC, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e du Delaware ayant son si\u00E8ge \u00E0 1345 Avenue of the Americas, New York, NY 10105, repr\u00E9sent\u00E9e par Michel Lussier, avec effet au 14 novembre 2023"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}29-12-2023 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-29",
"filing_date": "2023-12-27",
"act_kind_objet": "DEMISSIONS, NOMINATIONS, CAPITAL, ACTIONS"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"date": "2023-12-22",
"unanimous": true
},
"agm_change": null,
"detected_kind": "agm_rescheduling",
"other_address": null,
"mandate_renewal": {
"period_end": "2026",
"mandate_kind": "commissaire",
"period_start": null,
"remuneration_eur": null,
"remuneration_kind": null,
"person_or_entity_kbo": null,
"person_or_entity_name": "CFIP CLYD LLC"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "Celyad Oncology",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"accounts_deposit": {
"filing_kind": null,
"fiscal_year_end": "2022-12-31",
"filing_reference": null
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Berquin Notaires",
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une liste de pr\u00E9sences",
"le texte coordonn\u00E9 des statuts"
],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": {
"grantee_kbo": null,
"grantee_name": "Mme. An Phan, responsable juridique, et/ou Me Adrien Lanotte, et/ou \u00E0 tout avocat du cabinet Harvest Avocats",
"grantor_name": "Celyad Oncology",
"scope_summary": "Procuration pour ex\u00E9cuter et signer les documents n\u00E9cessaires \u00E0 l\u0027ex\u00E9cution des d\u00E9cisions de l\u0027assembl\u00E9e, y compris la publication au Moniteur belge, et pour r\u00E9diger, signer et d\u00E9poser la coordination des statuts.",
"monetary_cap_eur": null,
"scope_categories": [
"publication",
"personnel",
"other"
],
"termination_clause": null,
"substitution_allowed": true
},
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}20-12-2023 Capital increase of €7,749,999.92 to €88,378,224.25
- €80.628.224,33 → €88.378.224,25
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 7749999.92,
"currency": "EUR",
"after_eur": 88378224.25,
"delta_eur": 7749999.92,
"before_eur": 80628224.33,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-11-14",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la soci\u00E9t\u00E9 de 7.749.999,92 EUR pour le porter de 80.628.224,33 EUR \u00E0 88.378.224,25 EUR. L\u0027assembl\u00E9e d\u00E9cide que l\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 12000000,
"currency": "EUR",
"after_eur": 88378224.25,
"delta_eur": 7749999.92,
"before_eur": 80628224.33,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2023-11-14",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027approuver le renouvellement de l\u0027autorisation d\u0027utiliser la technique du capital autoris\u00E9, pour une nouvelle p\u00E9riode de 5 ans et \u00E0 concurrence d\u0027un montant maximal de 12.000.000 EUR",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}25-09-2023 Registered office moved from Mont-Saint-Guibert to Mont Saint Guibert
- Rue Edouard Belin 2, 1435 Mont-Saint-Guibert → Rue André Dumont 9, 1435 Mont Saint Guibert
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mont Saint Guibert",
"region": null,
"street": "Rue Andr\u00E9 Dumont",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "9"
},
"old_address": {
"city": "Mont-Saint-Guibert",
"region": null,
"street": "Rue Edouard Belin",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "2"
},
"effective_date": "2023-10-01",
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide de transf\u00E9rer le si\u00E8ge de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante : 9 rue Andr\u00E9 Dumont \u00E0 1435 Mont Saint Guibert. Ce transfert de si\u00E8ge prend effet le 1er octobre 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}11-09-2023 Capital increase of €2,044,000 to €80,628,224.33
- €78.584.224,33 → €80.628.224,33
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2044000.0,
"currency": "EUR",
"after_eur": 80628224.33,
"delta_eur": 2044000.0,
"before_eur": 78584224.33,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-09-04",
"evidence_quote": "Le conseil d\u0027administration d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de 2.044.000,00 EUR, pour le porter de 78.584.224,33 EUR \u00E0 80.628.224,33 EUR.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}11-07-2023 2 directors appointed
- Bert Kegels, Commissaris
- Georges Rawadi, Bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Bert Kegels",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "VCBA BDO Bedrijfsrevisoren - R\u00E9viseurs d\u0027entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Suite \u00E0 l\u0027arriv\u00E9e du terme du mandat de commissaire de CVBA E\u0026Y Bedrijfsrevisoren - R\u00E9viseurs d\u0027entreprises lors de la pr\u00E9sente assembl\u00E9e, l\u0027assembl\u00E9e d\u00E9cide de nommer comme commissaire VCBA BDO Bedrijfsrevisoren - R\u00E9viseurs d\u0027entreprises, ayant son si\u00E8ge \u00E0 1930 Zaventem, The Corporate Village, Da V"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Georges Rawadi",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SYGA BIO SARL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de confirmer la nomination de SYGA BIO SARL, dont le si\u00E8ge social est \u00E9tabli \u00E0 75011 Paris, 131 boulevard Charonne, repr\u00E9sent\u00E9e par Mr. Georges Rawadi, administrateur coopt\u00E9 par le conseil d\u0027administration en date du 23 mars 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}04-05-2023 1 director appointed, 1 resigning
- Georges Rawadi, Dagelijks bestuur
- Michel Lussier, Dagelijks bestuur
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Georges Rawadi",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SYGA BIO SARL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-04-17",
"evidence_quote": "Sur recommandation du Comit\u00E9 de R\u00E9mun\u00E9ration et de Nomination, le Conseil a approuv\u00E9 la nomination de SYGA BIO SARL, dont le si\u00E8ge social est \u00E9tabli \u00E0 75011 Paris, 131 boulevard Charonne, repr\u00E9sent\u00E9e par Monsieur Georges Rawadi, en qualit\u00E9 de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion jourmali\u00E8re de la Soci\u00E9t\u00E9, avec une "
},
{
"kind": "director_out",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-04-17",
"evidence_quote": "Mel Management SRL, repr\u00E9sent\u00E9e par Michel Lussier, demeurera d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re de la Soci\u00E9t\u00E9 jusqu\u0027au 17 avril 2023, date \u00E0 laquelle prendre fin son mandat de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re (sans impacter la poursuite de son mandat comme administrateur)."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}24-02-2023 Chris Buyse resigns as director
- Chris Buyse, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Chris Buyse",
"address": null,
"birth_date": null
},
"effective_date": "2022-12-13",
"evidence_quote": "Le Conseil d\u0027Administration a pris connaissance de la d\u00E9mission de Chris Buyse comme membre du Conseil avec prise d\u0027effet au 13 d\u00E9cembre 2022 \u00E0 minuit."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}14-10-2022 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-10-14",
"filing_date": "2022-10-12",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2022-10-05",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0891.118.115",
"name": "Celyad Oncology",
"role": "other",
"address": "Rue Edouard Belin 2, 1435 Mont-Saint-Guibert",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:198",
"7:179",
"7:180",
"7:191"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 323700,
"real_estate_included": false,
"patrimony_description": "L\u0027op\u00E9ration consiste en l\u0027\u00E9mission de 323.700 droits de souscription \u00E0 titre gratuit, permettant aux membres du personnel de la soci\u00E9t\u00E9 de souscrire \u00E0 de nouvelles actions ordinaires. L\u0027augmentation de capital est conditionnelle \u00E0 l\u0027exercice de ces droits.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "Celyad Oncology",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"detected_kind_raw": "capital_shares",
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le conseil d\u0027administration de Celyad Oncology, soci\u00E9t\u00E9 anonyme dont le si\u00E8ge est \u00E0 Mont-Saint-Guibert, a d\u00E9cid\u00E9, le 5 octobre 2022, d\u0027\u00E9mettre 323.700 droits de souscription \u00E0 titre gratuit \u00E0 destination des membres du personnel de la soci\u00E9t\u00E9. Ces droits peuvent \u00EAtre exerc\u00E9s jusqu\u0027au dixi\u00E8me anniversaire de leur \u00E9mission, et leur prix d\u0027exercice sera fix\u00E9 selon les r\u00E8gles l\u00E9gales applicables. L\u0027augmentation du capital, qui ne sera effective qu\u0027apr\u00E8s l\u0027exercice des droits, s\u0027\u00E9l\u00E8vera \u00E0 un montant maximal correspondant au nombre de droits exerc\u00E9s multipli\u00E9 par le pair comptable des actions exista",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une liste de pr\u00E9sence",
"le rapport du conseil d\u0027administration",
"le rapport du commissaire"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}20-07-2022 2 directors appointed, 1 resigning
- Michel Lussier, Dagelijks bestuur
- Hilde Windels, Bestuurder
- Filippo Petti, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-06-24",
"evidence_quote": "Sur recommandation du Comit\u00E9 de r\u00E9mun\u00E9ration et de nomination, le conseil a approuv\u00E9 la nomination de Mel Management SRL, repr\u00E9sent\u00E9e par Michel Lussier, en tant que d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re (CEO) de la Soci\u00E9t\u00E9, avec effet au 24 juin 2022."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-24",
"evidence_quote": "Sur recommandation du comit\u00E9 de r\u00E9mun\u00E9ration et de nomination repr\u00E9sent\u00E9 par Dominic Piscitelli et Michel Lussier, le conseil d\u0027administration a approuv\u00E9 la nomination de Hilde Windels en tant que pr\u00E9sidente du conseil d\u0027administration et pr\u00E9sidente du comit\u00E9 de r\u00E9mun\u00E9ration et de nomination, en rem"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filippo Petti",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-24",
"evidence_quote": "Le Conseil a pris note de la d\u00E9mission de Filippo Petti en tant que membre du conseil d\u0027administration, avec effet au 24 juin 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}31-05-2022 2 directors appointed, 1 reappointed
- Ami Patel SHAH, Bestuurder
- Christopher LIPUMA, Bestuurder
- Hilde Windels, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null
},
"evidence_quote": "Apr\u00E8s avoir constat\u00E9 l\u0027\u00E9ch\u00E9ance du mandat d\u0027administrateur de Madame Hilde Windels lors de la pr\u00E9sente r\u00E9union, l\u0027assembl\u00E9e d\u00E9cide de renouveler le mandat d\u0027administrateur de Madame Hilde Windels pour une dur\u00E9e de 4 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire ayant \u00E0 se prononcer sur les compte"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ami Patel SHAH",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de confirmer les nominations des administrateurs coopt\u00E9s par le conseil d\u0027administration en dates du 8 d\u00E9cembre 2021 et du 13 janvier 2022, \u00E0 savoir et respectivement: - Madame Ami Patel SHAH:"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christopher LIPUMA",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de confirmer les nominations des administrateurs coopt\u00E9s par le conseil d\u0027administration en dates du 8 d\u00E9cembre 2021 et du 13 janvier 2022, \u00E0 savoir et respectivement: ... - Monsieur Christopher LIPUMA."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}05-04-2022 2 reappointed
- Michel Lussier, Bestuurder
- Marina Udier Blagovic, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michel Lussier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Mel Management SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de confirmer la nomination de Mel Management SRL, repr\u00E9sent\u00E9e par Michel Lussier, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 pour une dur\u00E9e de 4 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2024."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marina Udier Blagovic",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de confirmer la nomination de Marina Udier Blagovic, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 pour une dur\u00E9e de 4 ans, soit jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire statuant sur les comptes de l\u0027exercice cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "CELYAD ONCOLOGY",
"legal_form": "SA"
}
}24-03-2022 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-03-24",
"filing_date": "2022-03-22",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2022-03-17",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0891.118.115",
"name": "Celyad Oncology",
"role": "other",
"address": "Rue Edouard Belin 2, 1435 Mont-Saint-Guibert",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "La modification concerne les conditions d\u0027exercice de 561.525 et 777.050 droits de souscription \u00E9mis par les conseils d\u0027administration des ann\u00E9es 2020 et 2021. La condition selon laquelle le prix d\u0027exercice devait \u00EAtre sup\u00E9rieur au pair comptable (3,48 EUR par action) est supprim\u00E9e.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0891.118.115",
"name_full": "Celyad Oncology",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le conseil d\u0027administration de Celyad Oncology, soci\u00E9t\u00E9 anonyme \u00E0 si\u00E8ge \u00E0 Mont-Saint-Guibert, a pris connaissance du rapport compl\u00E9mentaire et a d\u00E9cid\u00E9 de modifier les conditions d\u0027exercice de 561.525 et 777.050 droits de souscription \u00E9mis en 2020 et 2021. La condition selon laquelle le prix d\u0027exercice devait d\u00E9passer le pair comptable (3,48 EUR par action) est supprim\u00E9e. Les autres conditions restent applicables telles qu\u0027elles figurent dans les rapports des conseils d\u0027administration respectifs.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une liste de pr\u00E9sence",
"un rapport compl\u00E9mentaire du conseil d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 7 :198 juncto articles 7 :179 et 7 :180 du Code des soci\u00E9t\u00E9 et des associations"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}| Legal nameFR | Celyad Oncology |